A Debreceni Egyetem a Kossuth Lajos Tudományegyetem, a Debreceni Orvostudományi Egyetem, a Debreceni Agrártudományi Egyetem és a hajdúböszörményi Wargha István Pedagógiai Főiskola összevonásával jött létre 2000. január 1-jén.

During the past decade, University of Debrecen conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 15 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 11 clinical trials were completed. i.e. 157.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Debrecen" #1 sponsor was "University of Debrecen" with 4 trials, followed by "AOP Orphan Pharmaceuticals AG" with 3 trials sponsored, "Aires Pharmaceuticals, Inc." with 2 trials sponsored, "Incyte Corporation" with 2 trials sponsored and "Johns Hopkins University" with 2 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Debrecen" #1 collaborator was "Emissary International LLC" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "University of Debrecen" with 2 trials as a collaborator and "Accelovance" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "University of Debrecen" are "Polycythemia Vera" (3 trials), "Atrial Fibrillation" (2 trials), "Dermatomyositis" (2 trials), "Multiple Myeloma" (2 trials) and "Multiple Sclerosis" (2 trials). Many other conditions were trialed in "University of Debrecen" in a lesser frequency.

Most popular intervention types in "University of Debrecen" are "Drug" (35 trials), "Device" (7 trials), "Other" (6 trials), "Procedure" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Cyclophosphamide" (2 trials), "AIR001" (1 trials), "AIR001 (sodium nitrite inhalation solution)" (1 trials) and "Ablation / MRI" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Debrecen" are 48 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are 9 active trials in "University of Debrecen". 1 are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 38 completed trials in University of Debrecen, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in University of Debrecen, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 7 trials that are defined as “Not Applicable".